Larvol Delta - Allogene-Therapeutics-Announces-Journal-of-Clinical-Oncology-Publication-of-Phase-1-Results-of-ALLO316-Highlighting-First-Durable-Remissions-Following-Allogeneic-CAR-T-for-Treatment-of-Metastatic-Solid-Tumors

ALLO-316 - Allogene Overland Biopharm

https://www.globenewswire.com/news-release/2026/07/15/3327728/0/en/Allogene-Therapeutics-Announces-Journal-of-Clinical-Oncology-Publication-of-Phase-1-Results-of-ALLO-316-Highlighting-First-Durable-Remissions-Following-Allogeneic-CAR-T-for-Treatme.html

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next